Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Post by Frosch1on Mar 03, 2020 6:43am

187 Views

Post# 30759604

Japan

R+F makes 1'500 MUSD turnover (2018) per year of sales

skin lightener will be much more important in Japan than in the US.

100 USD per skin lightener tube.

What is the share of the skin lightener in total sales?

at 5% would be 75 MUSD / 100 USD per tube = 750'000 tubes x 0.8 USD = 600'000 USD Sales for Sirona

The skin lightener will be much more important in Japan, i.e. the share of sales in total sales will be much bigger...

Bullboard Posts

From now on, dynaCERT instead of Bitcoin or NVIDIA?